Followers | 25 |
Posts | 3216 |
Boards Moderated | 2 |
Alias Born | 04/11/2005 |
Thursday, April 29, 2010 9:06:33 AM
1) Does POZEN actually manufacture Treximet, or does GlaxoSmithKline, with POZEN having no overhead and 100% margins on it?
2) Why is POZEN choosing Astrazeneca to market VIMOVO instead of Glaxo? Seems strange that you would have different marketing/sales companies for your 2 drugs, unless either POZEN shops the drugs arounds and Astrazeneca simply gave them the best deal/contract, or maybe that Glaxo did not do a good job with Treximet, so POZEN is looking elsewhere. Anyone know the case here?
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM